MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517065770 A) filed by Gasherbrum Bio, Inc., San Francisco, on July 10, for 'salts and solid forms of a compound having glp-1 agonist activity.'
Inventor(s) include Chen, Libo; Gu, Xiaodong; and Jiang, Xinglong.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to salts and solid forms of a compound that is GLP-1 agonist, and its use as a therapeutic agent for treating diseases disorders, or conditions associated with GLP-1, such as type 2 diabetes mellitus (T2DM)."
The patent application was internationally filed...